$8.320
-0.345 (-4.15%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
RNA-Prognose durch Analyse ähnlicher Charts
Alphio's RNA stock price prediction model matches the current Atrium Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.37 (+0.57%). The 1-week path is $8.29 (-0.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Atrium Therapeutics Inc-Aktien kaufen?
Avidity Biosciences Inc (RNA) is a good buy right now due to its current price of $8.55, which is significantly below its 52-week high of $73.06, indicating substantial upside potential. The RSI of 70.53 suggests that the stock is currently overbought, but the recent 5-day change of +6.21% and a strong upcoming clinical trial could drive further interest. However, the main risk is the significant insider selling, which has increased by 200.63% over the last month, indicating potential concerns about future performance.
RNA schloss am Thursday bei $8.32, nachdem der Kurs -4.15% fallen
Atrium Therapeutics Inc (RNA) last closed at $8.3199997, losing -4.15%. These facts feed the 1-day and 1-week RNA price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Atrium Therapeutics Inc (RNA) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf RNA am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für RNA
Historically the probability of a positive November return for RNA is 90.70%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.